Amazon (AMZN) announced the Buy with Prime app for Shopify (SHOP), a new app integration that makes it easy for merchants to offer Buy with Prime on Shopify stores. The Buy with Prime app for Shopify gives Prime members the option to select Buy with Prime on a product’s detail page before completing their order within Shopify’s Checkout. Buy with Prime offers Prime members fast, free delivery and easy returns through Amazon’s fulfillment network. After signing into their Amazon accounts, Prime members pay for their orders using a payment method from their Amazon wallets and Shopify Payments will process the payment through Shopify’s Checkout. The app will start rolling out as invite-only to select Shopify merchants today, and it will be available to all U.S.-based Shopify merchants who are already using or want to use Amazon’s fulfillment network by the end of September. “We’ve been thrilled with the feedback merchants have shared about Buy with Prime, including the increased shopper conversion and new shopper acquisition,” said Peter Larsen, Amazon vice president of Buy with Prime. “The build of this app was a collaboration with Shopify, and we’re excited to help merchants not only grow their businesses, but also save time and resources-all while giving Prime members even more places to enjoy their shopping benefits.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMZN:
- Shopify’s (NYSE:SHOP) Amazon Partnership Could Boost Its Merchant Base
- 7 Magnificent Stocks: Hedge Funds are Loading Up; Should Investors Follow?
- Hundreds of ETFs are Closing Up Shop This Year. Here’s Why.
- Amazon (NASDAQ:AMZN) Hit with New FDA Probe
- Amazon threatened with legal action from FDA over ‘unapproved’ drugs, FT says
